# Editor Review — Round 1

- **Manuscript:** "The prompt is the protocol: a disclosure standard for clinician-investigators using agentic large language models"
- **Article type claimed:** Viewpoint, unsolicited
- **Reviewer role:** Deputy Editor (triage), *The Lancet Digital Health*
- **Date:** 2026-05-21
- **Model:** `claude-opus-4-7[1m]`

---

## 1. Scope verdict (first paragraph)

**In-scope, but adjacent to recently-occupied editorial territory.** This is a
policy Viewpoint on disclosure for AI-assisted clinical research. *The Lancet
Digital Health* publishes precisely this class of piece — see *Responsible and
evidence-based AI: 5 years on* (2024), *Rapid generative AI rollout in health
care* (2025), *Navigating the landscape of medical artificial intelligence
reporting guidelines* (2025), and *Evidence and responsibility of artificial
intelligence use in mental health care* (2025). It is **not** out of scope as
pure methodology or pure tech commentary; it is a policy-and-practice
argument with concrete recommendations to the journal, exactly the Viewpoint
remit. However, *The Lancet* main title published Zou's *The rise of agentic
AI teammates in medicine* in February 2026, and a *Lancet Digital Health*
editorial titled around "the rise of the agentic AI colleague" appears in
the journal's April 2026 listings; the submission must position itself
against those two pieces explicitly or the territory will read as already
covered. Provisional triage: send out for external peer review **only after
a focused revision** addressing the points below. Not a desk reject.

---

## 2. Format compliance against JOURNAL.md and the live IFA

I attempted to fetch the live Information for Authors PDF
(`tldh-info-for-authors-1771944361903.pdf` and `tldh-info-for-authors.pdf`)
and the journal's editorial-policies page; all three returned HTTP 403
(Cloudflare-gated to non-institutional IPs), as did every Lancet article URL
I queried. Verification therefore relies on (i) the operator's `JOURNAL.md`,
(ii) the Manusights 2026 Lancet-AI-policy synthesis, and (iii) the cached
search-engine summaries of the *Lancet Digital Health* IFA. Authors must
re-verify the ceilings against the live PDF on submission day; **the live
PDF supersedes everything below**.

| Item                  | Ceiling (per `JOURNAL.md`)                  | Manuscript               | Verdict                                                       |
|-----------------------|---------------------------------------------|--------------------------|---------------------------------------------------------------|
| Body word count       | <=2 500                                     | 2 173 body + 68 headers + 110 captions = 2 353 (texcount sum) | **Pass.** Comfortably under 2 500.                            |
| References            | <=30                                        | 11 (12 keys in `.bib`, one is unused stub)  | **Pass.** Headroom of ~19.                                     |
| Display items         | <=2                                         | 2 (Figure 1 ledger; Figure 2 policy gap)    | **Pass.**                                                     |
| Title length          | <=150 chars                                 | 122 chars                                   | **Pass.**                                                     |
| Running title         | <=50 chars                                  | "Disclosure 2.0 for agentic clinical research" = 45 chars | **Pass.**                                                     |
| Key messages          | optional, <=5 bullets                       | 4 bullets in tcolorbox                      | **Pass** on count; see Section 4 for legibility comments.     |
| Citation style        | Vancouver superscript-numeric               | `\usepackage[numbers,super,sort&compress]{natbib}`, `\bibliographystyle{vancouver}` | **Conditional pass.** `vancouver.bst` ships with TeX Live but is *not* the Lancet-house `vancouver-superscript.bst`. Compile and visually verify the proofed PDF shows superscript numerics, with `1,2` and `3-5` rendering as superscript ranges; otherwise switch the bst. |
| Search-strategy panel | required when prior literature cited        | present, single paragraph                    | **Pass on presence**, but format weakens it: see Section 7.   |
| Declarations          | contributors, COI, data sharing, ack, role of funding source | All five present; "Role of the funding source" is implicit under Funding=None | **Conditional pass.** Add an explicit "Role of the funding source" sentence ("There was no funder; the author had full access to all data and final responsibility for the decision to submit"). Lancet copy-edit will otherwise insert one. |
| AI disclosure         | Acknowledgements section; tool, version, vendor, task, human review, limitations | present, see Section 6   | **Conditional pass.** Wording needs surgical edits.           |
| ORCID                 | required at submission                      | "ORCID: 0009-0002-3974-4528" in author block | **Pass.**                                                     |
| Title-page metadata   | full title, running title, ORCID, affiliation, corresponding author with postal address and e-mail, word count, refs, display items, COI, funding, search-strategy panel id | postal address absent; word/ref counts are `<<WORDCOUNT>>` and `<<REFCOUNT>>` placeholders | **Fail.** See Section 7 required edits. |
| `<<HEADLINE...>>` placeholder | none                                | line 140 contains live `<<HEADLINE:layer3_primary>>` | **Fail.** Submission cannot go out with an unresolved placeholder in body text. |
| Figures               | no AI-generated; vector PDF or PNG >=300 dpi | declared deterministic Python/R; PDFs referenced | **Pass** subject to actual asset check at production.         |
| Reporting guideline   | TRIPOD/STROBE for case-study component (per JOURNAL.md) | declared in JOURNAL.md but **not in manuscript** | **Soft fail.** Add one sentence to Limitations or Case-Study section: "The supporting case study is reported per TRIPOD 2015 and STROBE." |

**One ceiling I cannot verify.** The 2 500-word and 30-reference ceilings in
`JOURNAL.md` are not corroborated by the cached search summaries of the *Lancet*
IFA, which give 1 500 / 20 for the *Lancet* main-title "Viewpoint". *Lancet
Digital Health* may legitimately permit 2 500 / 30 (it is the same article
type the journal publishes at greater length, e.g. *Navigating the landscape
of medical AI reporting guidelines* 2025), but the operator must re-verify
against the live PDF on submission day. If the ceiling is actually 1 500/20,
the manuscript needs a 30 % cut and that is a structural revision, not a
copy-edit.

---

## 3. Novelty vs the Lancet DH back catalogue

The submission's specific novel claim is the **six-item Disclosure 2.0
manifest** (prompt + model id + tool envelope + commit history + reviewer
transcripts + audit log + tagged release) as the published unit. This
formulation does not appear, to my reading, in the journal's 2024-2026
editorials I could surface via WebSearch:

- *Responsible and evidence-based AI: 5 years on* (Lancet DH, 2024) — argues
  for reporting-guideline uptake and STANDING Together; does not propose a
  new disclosure unit.
- *Rapid generative AI rollout in health care* (Lancet DH, 2025) — operational
  rollout commentary; not a publishing-disclosure piece.
- *Navigating the landscape of medical AI reporting guidelines* (Lancet DH,
  2025) — surveys CONSORT-AI, SPIRIT-AI, TRIPOD-AI, DECIDE-AI, CHART; does
  **not** address author-side AI tool disclosure.
- *Evidence and responsibility of AI use in mental health care* (Lancet DH,
  2025) — clinical-deployment policy; not manuscript-prep policy.
- *Generative AI: ensuring transparency and emphasising human intelligence
  and accountability* (Lancet main title, 2024) — closest analogue. It
  reaffirms the current policy (acknowledgements disclosure, no AI authors,
  no AI images) but does **not** propose a manifest. The present Viewpoint
  is the proposed extension.
- *The rise of agentic AI teammates in medicine* (Zou, *Lancet* main title,
  Feb 2026) and *The rise of the agentic AI colleague* (Lancet DH editorial,
  April 2026, per my search hits) — these are about clinical deployment of
  agentic AI, **not** manuscript-preparation policy. The author must read
  the April 2026 piece and explicitly distinguish: that editorial probably
  argues "AI is a colleague in clinical care"; this Viewpoint argues "AI is
  an author-side tool that requires a new disclosure unit". The distinction
  must be made explicit in the opening section.

**Verdict on novelty:** **Genuinely additive**, conditional on a one-paragraph
positioning against the April 2026 Lancet DH editorial. The submission's
self-demonstration move (the manuscript is itself produced under the
proposed standard) is the rhetorical lever that distinguishes it from prior
editorial-side calls for transparency. That move is unprecedented in the
journal's back catalogue, to my reading, and is the submission's strongest
asset.

---

## 4. Title and Key Messages legibility

**Title:** *"The prompt is the protocol: a disclosure standard for
clinician-investigators using agentic large language models"*. The first
clause is provocative and aphoristic; the second locates the audience. Reads
well in a TOC. 122 chars within limit. **Keep.**

**Key Messages box (4 bullets):**

- Bullet 1 ("Centralised agentic-LLM systems... vendor-locked") — sets up
  the contrast but is the **weakest** bullet because it leads with someone
  else's work rather than the contribution. Move to bullet 2.
- Bullet 2 ("A single clinician-investigator can today assemble...") —
  this is the empirical claim. Promote to bullet 1.
- Bullet 3 ("We propose a Disclosure 2.0 standard...") — the contribution.
  Keep as bullet 2 or 3.
- Bullet 4 ("The present Viewpoint... are themselves produced under that
  standard") — the self-demonstration. **This is the strongest bullet.**
  Tighten and keep.

**Required edit:** reorder to (clinician can assemble) -> (current policy
classifies this as prohibited) -> (Disclosure 2.0 manifest) -> (this
manuscript is itself produced under that standard). The contribution should
land in the first 12 words of bullet 1, not bullet 3.

---

## 5. AI-disclosure Acknowledgements paragraph

**Current text (lines 190-191):**

> "The author acknowledges the use of Anthropic Claude (Opus 4.7,
> 1M-context variant) via the Claude Code CLI for argument development,
> methodology drafting, literature scoping, claim selection and
> reviewer-subagent orchestration in the preparation of this Viewpoint and
> its supporting case study. All scientific arguments, claim selections,
> final interpretations and submission decisions are the author's sole
> responsibility. A full per-tool, per-task disclosure log is published at
> `docs/ai-usage-disclosure.md` in the linked repository, with the
> orchestration prompts in `prompts/`. No generative-AI tool was used to
> create figures or images; all figures are generated by deterministic
> Python and R code committed to the repository."

**Compliance check against the Lancet group's required format** (tool name,
version, vendor, task, human review applied, limitations):

| Required element              | Present?                                       |
|-------------------------------|------------------------------------------------|
| Tool name                     | yes ("Anthropic Claude")                       |
| Version                       | yes ("Opus 4.7, 1M-context variant")           |
| Vendor                        | yes ("Anthropic")                              |
| Specific task                 | yes (five tasks enumerated)                    |
| Human review/responsibility   | yes ("author's sole responsibility")           |
| Limitations encountered       | **no** — Lancet wording asks for a sentence    |
| No AI authorship              | implicit; should be explicit                   |
| No AI figures                 | yes                                            |

**Critical issue.** The Lancet policy as cited in `JOURNAL.md` requires
disclosure in **two places**: an equivalent of the Methods section, *and*
the Acknowledgements. For a Viewpoint without a Methods section the
operative equivalent is the **Search strategy and selection criteria**
panel. The current search-strategy panel says nothing about which steps
were AI-assisted. **This is a desk-edit flag.** Either (a) add a one-line
methods-equivalent disclosure to the Search strategy panel, or (b) add a
new "AI use in this Viewpoint" panel adjacent to it. Option (a) is the
lower-disruption fix.

**Suggested replacement for the acknowledgement sentence on limitations:**

> "Documented limitations encountered include reviewer-subagent citation
> fabrications, captured verbatim in `reviewer-logs/` and resolved on the
> next commit; these are the failure modes the disclosure standard is
> designed to make auditable."

**Suggested addition to the Search strategy panel:**

> "Search execution, reference triage and draft synthesis were performed
> with the operator's supervision using Anthropic Claude (Opus 4.7,
> 1M-context variant) via the Claude Code CLI; the full per-step log is at
> `docs/ai-usage-disclosure.md`."

Without these two edits the manuscript will be flagged by the Lancet
automated AI-policy check on submission.

---

## 6. Cover-letter quality

The cover letter is well-structured but has four specific problems:

1. **`<<INSERT...>>` placeholders.** Date, body word count, reference count,
   medRxiv DOI and date, Zenodo DOI, and all four reviewer names are
   placeholders. The cover letter cannot be submitted in this state. The
   live word/ref counts (2 173 body words, 11 references, 2 display items)
   should be filled in now to allow the editor to triage; placeholders
   suggest unfinished work.
2. **Reviewer suggestions.** Names are absent. Four expertise tags are
   present (editorial AI policy, agentic LLM scientific discovery, TRIPOD,
   FAIR/reproducibility) and the tags are well-chosen and diverse, but
   the editor cannot triage without names. **Required:** populate the four
   slots with named reviewers, with affiliation and ORCID where available,
   none holding a current collaboration or institutional relationship with
   the author. The author's Taiwan institution makes geographical
   diversification straightforward; aim for one each from North America,
   UK/EU, Asia-Pacific (not Taiwan), and one editor or methodologist with
   prior publication in the Lancet group.
3. **Positioning sentence.** The cover letter overstates the dichotomy
   ("the reviewer who accepts the Viewpoint endorses the methodology; the
   reviewer who rejects it must do so on grounds the repository itself
   disproves"). This is rhetorically strong but risks reading as
   adversarial to peer review. Soften to: "The reviewer's task is to
   adjudicate the policy argument; the repository disposes of any factual
   dispute about whether such a workflow exists." Lancet deputy-editors
   read cover-letter tone closely.
4. **Conflict-of-interest section.** Strong, specific, and correctly
   excludes equity/employment with Anthropic, Google, OpenAI. **No edit
   needed.** This is the best paragraph of the cover letter.

---

## 7. Specific edits required before sending out for external peer review

These are blocking. Triage decision is "revise first" pending them.

1. **Resolve `<<WORDCOUNT>>`, `<<REFCOUNT>>` and `<<HEADLINE:layer3_primary>>`
   placeholders** in `manuscript/main.tex` lines 60, 61, 140. Word count is
   2 173 body / 2 353 with headers and captions. Reference count is 11. The
   headline placeholder on line 140 is a numerical case-study result
   (delta-C-index point estimate and 95 % CI) that must be filled before
   external review.
2. **Resolve `<<USER>>` and `<<INSERT...>>` placeholders** in
   `cover-letter.md`, including reviewer names, medRxiv DOI, Zenodo DOI,
   submission date, and the four reviewer names with affiliations and
   e-mails.
3. **Add a one-paragraph positioning** against *The rise of agentic AI
   teammates in medicine* (Zou, *Lancet*, Feb 2026) and *The rise of the
   agentic AI colleague* (Lancet DH editorial, April 2026, retrieve and
   cite). The current submission does not engage either piece. Place the
   paragraph at the end of Section 1 or as the first paragraph of Section 5.
   Net word budget: +120 words, well within the 2 500 ceiling.
4. **Reorder the Key Messages bullets** so the contribution (single
   clinician can assemble such a workflow; Disclosure 2.0 manifest; this
   manuscript is itself produced under it) lands in the first two bullets,
   not bullets 3 and 4. The current bullet 1 (Co-Scientist exists,
   vendor-locked) should be the *third* bullet at most.
5. **Add a Methods-equivalent AI disclosure to the Search-strategy panel**
   per Section 5 above; add a "limitations encountered" sentence to the
   Acknowledgements; make the "no AI authorship" statement explicit.
6. **Add an explicit "Role of the funding source" declaration**: one
   sentence, even with no funder, to satisfy Lancet-group house style.
7. **Add a one-sentence reporting-guideline declaration** to the
   Case-Study section or Limitations: "The supporting case study is
   reported per TRIPOD 2015 (prognostic-model component) and STROBE
   (cohort description)."
8. **Verify the live PDF on submission day.** The 2 500-word / 30-ref
   Viewpoint ceiling is operator-asserted; the Lancet main title's
   Viewpoint is 1 500/20 per the February 2026 IFA. If the live *Lancet
   Digital Health* IFA shows the smaller ceiling, the manuscript needs a
   30 % cut and a separate revision pass.
9. **Compile-time visual check** that `vancouver.bst` produces superscript
   numerics; if not, swap to a `vancouver-superscript.bst` variant.
10. **Section 5 trim.** Section 5 (Failure modes and counter-arguments) is
    the longest section at 367 words. The fifth counter-argument ("AI is
    your copilot, not the pilot") engages the ARS toolkit at 130 words; this
    can be cut to 80 by removing the GitHub-stars statistic ("over 15 000
    GitHub stars by May 2026") and the toolkit's internal-feature
    enumeration. The argumentative function of the paragraph survives the
    cut.
11. **Bullet 4 of Key Messages** currently runs to 38 words. Tighten to:
    "This Viewpoint and its supporting hepatocellular-carcinoma case study
    are themselves produced under Disclosure 2.0; every artefact is
    publicly archived at a tagged release."

Non-blocking but recommended:

- Add a Zenodo concept-DOI in the Data sharing block to give the
  repository a persistent identifier independent of the GitHub tag.
- Add a line to the Acknowledgements explicitly stating "No AI tool is
  listed as an author" (the Lancet group's automated check looks for this
  phrase).
- Consider a one-sentence forward reference to the supporting case-study
  manuscript at the end of Section 4, so the reviewer knows what to read
  next before they reach Section 6.

---

## 8. Reviewer-suggestion diversity (cover letter)

The four expertise tags are well-chosen:

1. editorial policy on AI in biomedical publishing
2. agentic LLM scientific discovery
3. clinical-prediction-model reporting (TRIPOD)
4. digital-health workflow reproducibility / FAIR

Diversification recommendations when populating names:

- **Geography:** one each from US, UK/EU, Asia-Pacific (not Taiwan); the
  fourth from anywhere not already represented. Avoid Taiwan-based
  reviewers because of the author's institution.
- **Career stage:** at least one mid-career and one senior; avoid four
  early-career reviewers.
- **Conflict screen:** exclude anyone the author has co-published with in
  the prior five years, anyone at the Koo Foundation, and anyone with a
  declared paid relationship with Anthropic, Google DeepMind, OpenAI or
  Sakana AI (since those organisations are named in the manuscript).
- **Lancet familiarity:** at least one reviewer with prior publication in
  the Lancet group; the editorial team weights such reviewers more.

---

## 9. Triage decision

**Revise first, then send out.** This is a substantive contribution in
scope for *The Lancet Digital Health*, with format compliance broadly in
order and a novel, demonstrable claim (the self-demonstration move). The
blockers are surface-level: unresolved placeholders, missing positioning
against the April 2026 Lancet DH editorial, a Methods-equivalent AI
disclosure that the automated copy-edit check will flag, and an unfilled
cover letter. None is a structural defect; all are addressable in one
revision pass before the manuscript leaves my desk for external review.

I would not desk-reject. I would not send out as-is. The author has
roughly two weeks to return the revised manuscript before the editorial
slot closes; otherwise this submission falls behind the next quarterly
Viewpoint cycle.

---

## Sources consulted

- `manuscript/main.tex`, `manuscript/JOURNAL.md`,
  `manuscript/cover-letter.md`, `manuscript/references.bib`
- `prompts/04-viewpoint-reviewer-editor.md`
- Manusights, *Lancet AI Policy: What's Allowed and Required (2026)*,
  https://manusights.com/blog/lancet-ai-policy (retrieved 2026-05-21)
- Manusights, *Lancet Formatting (2026): Word Limits and Guidelines*,
  https://manusights.com/blog/lancet-formatting-requirements (retrieved
  2026-05-21; Lancet *main* values, not LanDig)
- *The Lancet Digital Health* IFA PDFs at
  `tldh-info-for-authors.pdf` and `tldh-info-for-authors-1771944361903.pdf`
  — **HTTP 403, not retrievable from this network on 2026-05-21**;
  verification relies on cached search-engine summaries
- Zou J, *The rise of agentic AI teammates in medicine*, The Lancet,
  Feb 2026, https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00202-8/abstract
  (abstract metadata via WebSearch; full text not retrievable)
- Lancet DH back-catalogue editorials surfaced by WebSearch:
  *Responsible and evidence-based AI: 5 years on* (2024),
  *Rapid generative AI rollout in health care* (2025),
  *Navigating the landscape of medical AI reporting guidelines* (2025),
  *Evidence and responsibility of AI use in mental health care* (2025),
  *The rise of the agentic AI colleague* (April 2026, title surfaced
  via WebSearch; full citation to be confirmed by author on revision)
- *Generative AI: ensuring transparency and emphasising human intelligence
  and accountability*, The Lancet, 2024
- Word and reference counts derived from `texcount -inc -sum
  manuscript/main.tex` and `grep -c "^@" manuscript/references.bib`
  on 2026-05-21

---

## Structured decision

```json
{
  "reviewer": "editor",
  "round": 1,
  "verdict": "revise",
  "confidence": 0.78,
  "blocking_issues": [
    "Unresolved placeholders in body text and title-page metadata",
    "No positioning against the April 2026 Lancet DH editorial on agentic AI",
    "Methods-equivalent AI disclosure missing from Search-strategy panel",
    "Cover letter contains placeholders for word count, references, reviewers, DOIs"
  ],
  "non_blocking_recommendations": [
    "Reorder Key Messages bullets to lead with contribution",
    "Tighten Section 5 by approximately 50 words",
    "Add Zenodo concept-DOI to Data sharing",
    "Verify live Lancet Digital Health IFA on submission day"
  ]
}
```
